about
An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocainePICK1 deficiency impairs secretory vesicle biogenesis and leads to growth retardation and decreased glucose toleranceNeuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamineIncreased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice.GABAA receptor antisense epilepsy: histological changes following infusion of antisense oligodeoxynucleotide to GABAA receptor gamma 2 subunit into rat hippocampus.Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in ratsAssociation between genes on chromosome 19p13.2 and panic disorder.A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene.Differential Effect of Neuropeptides on Excitatory Synaptic Transmission in Human Epileptic Hippocampus.Neuropeptide Y and seizures: effects of exogenously applied ligands.Optogenetic control of human neurons in organotypic brain cultures.A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporterAnxiolytic-Like Effects of Increased Ghrelin Receptor Signaling in the Amygdala.Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice.MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro.Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.The role of NPY in learning and memory.Exploring the Behavioral and Metabolic Phenotype Generated by Re-Introduction of the Ghrelin Receptor in the Ventral Tegmental Area.Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.Effects of amphetamine and methylphenidate on attentional performance and impulsivity in the mouse 5-Choice Serial Reaction Time Task.Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time task.Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.Addiction-related effects of DOV 216,303 and cocaine: A comparative study in the mouse.Chemogenetic Modulation of G Protein-Coupled Receptor Signalling in Visual Attention Research.Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice.Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.Neuropeptide Y promotes neurogenesis in murine subventricular zone.[Optogenetics brings hidden neural mechanisms into the light and could become a future therapy].Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro.Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.Gene expression in the neuropeptide Y system during ethanol withdrawal kindling in rats.Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions.Are TMEM genes potential candidate genes for panic disorder?Role for M5 muscarinic acetylcholine receptors in cocaine addiction.Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.DREADDs suppress seizure-like activity in a mouse model of pharmacoresistant epileptic brain tissue.Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice.
P50
Q24608616-A99EA5C0-FDA9-4E4E-849F-B9D8D95E5EDDQ27317876-37F4F2A8-F7B8-4417-844B-939999ADB7A7Q28577357-EF57E504-BFF7-4B90-873D-B548669FCBF6Q30566770-111C9C4E-93D9-4B69-9D09-2D4E0D706C8FQ32039188-E14A3B1D-3820-47B1-B267-03226F4CB2F4Q33748306-4A9BDA1F-6BB2-4CD1-B72F-BFAD68EBC352Q34539936-4B3764CA-8B27-45CB-A61B-C498E7223241Q35603666-9FB89F90-4800-4311-A67E-1EFB3395A8D0Q35680811-6454030C-F5C5-4C7F-BF38-BD31AC639CD3Q35874630-6C9BFBA0-53C9-4C2F-A700-32464747A9C8Q35995266-5990E72F-EB64-4A87-A971-D4CDD60104ADQ36822479-858C62A5-623B-430D-AAB6-826F91C98D22Q36950573-7DBF6946-8AA1-4DBE-85AC-5BD687220929Q37189583-BAC8FADE-8054-412A-AB0F-013F058C9B16Q37539911-D0A79433-A6BC-4D0B-8DC2-6F423F434C55Q37547270-326BCDE2-5D0A-41DD-8A32-92BE273B0229Q38590442-8D4ECB28-BEE7-445C-81B3-4D2C6B23B424Q38603840-6141ED84-EAA2-4ACD-8885-3832BF54BCFAQ38818599-8EE6F8EE-3EAA-4996-BA12-053D484C53AEQ38938538-46FEFC65-E576-428A-831F-F5EF97D71A01Q39017936-9AEE459E-7555-4E4B-BB52-95F6F61F894BQ39030164-957E4019-665A-4757-9D3C-38F53218C708Q39121322-19D03598-647D-4A28-B664-7B4DE65D2511Q39299851-1D4ADC96-B446-4CAC-BC56-39D5576581C4Q39369789-E5BB26A2-52B7-4E80-B380-1FD9615624DFQ39700861-0061A0E2-7DAB-4C6E-9778-C66F8E9C8BD7Q39758681-52287003-2370-4FEE-A1AC-341185BC9001Q39789571-6311AA46-94FA-432E-AB52-379689448AF3Q40106620-08DE5DD5-D537-4A36-AE2F-D93AA701401DQ41439484-D336E568-38DE-425A-861A-6545BED6C409Q41863270-C451FAB3-432F-4082-A061-7EDBD3641DF5Q42944984-4474AC53-9DCF-4AA9-9412-BDC8E37CDB92Q43211648-70D7874F-837D-4B4C-83A0-D8B9EF6F6787Q43599701-D680B36C-CAA8-466B-BD49-E7D45F1595B1Q44362047-132C4F8D-444B-49EC-A8CD-1D5A7657A4A7Q44586813-BB4710B3-C5FA-4F74-A2C4-2FBA4ABF3CBEQ44735526-3422B294-55B3-4BD8-B61B-11A85697B708Q45856308-4C814DF4-297F-4420-B720-9B25AF102B9CQ45872925-FFBB414D-74C9-48B0-9200-8D1C323DFB42Q46691341-1ADC139E-2F98-40F9-88D5-8DE6FA5D1DEC
P50
description
researcher ORCID ID = 0000-0002-6321-3850
@en
wetenschapper
@nl
name
D Woldbye
@ast
D Woldbye
@en
D Woldbye
@nl
type
label
D Woldbye
@ast
D Woldbye
@en
D Woldbye
@nl
prefLabel
D Woldbye
@ast
D Woldbye
@en
D Woldbye
@nl
P31
P496
0000-0002-6321-3850